Skip to content

Checked

Targeted Treatment for Advanced Non-Small Cell Lung Cancer That Has Increased Copies of the MET Gene (An Expanded Lung-MAP Treatment Trial)

NCT06116682 on ClinicalTrials.gov

Study listings come from ClinicalTrials.gov, where sponsors register and update their own studies. A listing does not mean a study is safe or effective, and DatenUS does not recommend any study. Talk with your doctor before joining a clinical trial, and use ClinicalTrials.gov for contact details and full eligibility rules.

Status
Recruiting
Phase
Phase 2
Interventional
Planned enrollment
88
Participants, all sites
U.S. sites
271
In 35 states

Study details

Conditions
Lung Non-Small Cell Carcinoma
Sponsor
SWOG Cancer Research Network (Research network)
Ages
18 years and older
Sex
All
Healthy volunteers
Not accepted
Start
11/19/2024
Primary completion (expected)
05/31/2028
Last updated by sponsor
10/09/2026

Full eligibility rules, contacts and site names: NCT06116682 on ClinicalTrials.gov

Where the study has sites

Cities with at least one listed U.S. site. Some sites may not be enrolling yet.

  • Arkansas: Jonesboro, Little Rock
  • California: Sacramento (2), Auburn, Berkeley, Fremont, La Jolla, Loma Linda, Modesto, Palo Alto, Rancho Mirage, Roseville, San Francisco, San Mateo and 4 more
  • Colorado: Colorado Springs (2), Fort Collins (2), Aurora, Greeley, Loveland
  • Connecticut: Derby, Fairfield, Guilford, New Haven, North Haven, Trumbull, Waterbury
  • Delaware: Dover, Milford
  • Florida: Gainesville, Jacksonville
  • Georgia: Atlanta (2), Gainesville
  • Hawaii: Honolulu (6), ‘Aiea (2), ‘Ewa Beach
  • Idaho: Boise, Caldwell, Coeur d'Alene, Nampa, Post Falls, Sandpoint
  • Illinois: Springfield (3), Chicago (2), Decatur (2), Effingham (2), Libertyville (2), Oak Lawn (2), Aurora, Barrington, Bloomington, Canton, Carthage, Crystal Lake and 28 more
  • Indiana: Indianapolis (2), Munster (2), Crown Point, Dyer, Hobart, Valparaiso
  • Iowa: Ames (2), Boone, Cedar Rapids, Fort Dodge, Jefferson, Marshalltown
  • Kansas: Overland Park (2), Fairway, Hays, Kansas City, Lawrence, Olathe, Salina, Topeka, Westwood
  • Kentucky: Lexington
  • Maine: Brewer
  • Massachusetts: Beverly, Burlington, Gloucester, Peabody, Springfield, Worcester
  • Michigan: Flint (4), Kalamazoo (2), Ann Arbor, Battle Creek, Brighton, Brownstown, Canton, Chelsea, Clinton Township, Dearborn, Detroit, Grand Rapids and 15 more
  • Minnesota: Deer River, Duluth, Hibbing, Rochester, Sandstone, Virginia
  • Mississippi: Columbus, Grenada, New Albany, Oxford, Southhaven
  • Missouri: Kansas City (3), St Louis (2), Cape Girardeau, Farmington, Lee's Summit, Sainte Genevieve, Sullivan
  • Montana: Anaconda, Billings, Bozeman, Great Falls, Kalispell, Missoula
  • Nevada: Las Vegas (2)
  • New Hampshire: Concord, Manchester
  • New Jersey: Moorestown, Voorhees Township
  • Ohio: Canton, Columbus, Sylvania
  • Oklahoma: Lawton, Oklahoma City
  • Oregon: Portland (4), Newberg, Ontario, Oregon City
  • Pennsylvania: Pittsburgh (3), York (2), Chambersburg, Danville, Dickson City, Ephrata, Erie, Gettysburg, Greensburg, Hanover, Harrisburg, Indiana and 7 more
  • South Carolina: Charleston
  • Tennessee: Collierville, Memphis
  • Utah: Salt Lake City
  • Virginia: Richmond (3), Charlottesville, South Hill
  • Washington: Edmonds, Issaquah, Seattle
  • West Virginia: Huntington, Morgantown
  • Wisconsin: Milwaukee (3), Ashland, Burlington, Cudahy, Germantown, Grafton, Green Bay, Kenosha, La Crosse, Marinette, Oshkosh, Racine and 7 more

More studies on the same topic

Frequently asked questions

What does recruiting mean?
Recruiting means the study is currently enrolling participants. Not yet recruiting means it has been registered but has not started enrolling. Enrolling by invitation means participants are selected by the study team rather than through open enrollment.
How do I join a clinical trial?
Read the full eligibility criteria and contact information on ClinicalTrials.gov, then talk with your doctor about whether a study may be right for you. The study team decides who can enroll.

Source: ClinicalTrials.gov, National Library of Medicine · Last updated 10/09/2026